Key facts
- This page summarizes Christopher M. Crane's Form 4 filing for EXELON CORP (EXC).
- 5 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 10 Jan 2022, 16:19.
Christopher M. Crane - 06 Jan 2022 Form 4 Insider Report for EXELON CORP (EXC)
- Reporting relationship
- President and CEO, Director
- Issuer ticker
- EXC
- Reported as of
- 06 Jan 2022
- Net transaction value
- -$1,981,239
- SEC form
- 4
- Accepted by SEC
- 10 Jan 2022, 16:19:42 UTC
- Prior SEC filing
- 22 Nov 2021
- Next SEC filing
- 10 Feb 2022
- Source filing
- View source filing
- Reporting owner signature
- Elizabeth M. Hensen, Attorney-in-Fact for Christopher M. Crane
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Christopher M. Crane filed Form 4 for EXELON CORP (EXC) on 10 Jan 2022.
Change
- Previous filing in this sequence was filed on 22 Nov 2021.
- Current net transaction value: -$1,981,239.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EXC
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +84,514
- Change %
- +35%
- Price
- Shares after
- 329,175
- Date
- 06 Jan 2022
- Ownership
- Direct
- Footnotes
- F1, F7
EXC
transaction
Common Stock
Tax liability
- Transaction value
- $1,981,239
- Shares
- -34,924
- Change %
- -11%
- Price
- $56.73
- Shares after
- 294,252
- Date
- 06 Jan 2022
- Ownership
- Direct
EXC
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 28,500
- Date
- 06 Jan 2022
- Ownership
- Held by trust for benefit of son
EXC
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 28,500
- Date
- 06 Jan 2022
- Ownership
- Held by trust for benefit of daughter
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
EXC
transaction
Derivative
2019 Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -28,254
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 06 Jan 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 28,254
- Exercise price
- $0.000000
- Footnotes
- F2, F3
EXC
transaction
Derivative
2020 Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -27,450
- Change %
- -50%
- Price
- Shares after
- 27,450
- Date
- 06 Jan 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 27,450
- Exercise price
- $0.000000
- Footnotes
- F2, F4
EXC
transaction
Derivative
2021 Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -28,810
- Change %
- -33%
- Price
- Shares after
- 57,619
- Date
- 06 Jan 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 28,810
- Exercise price
- $0.000000
- Footnotes
- F2, F5
EXC
holding
Derivative
Deferred Compensation Phantom Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 7,152
- Date
- 06 Jan 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,152
- Exercise price
- $0.000000
- Footnotes
- F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 7 footnotes
Footnote F1
Common shares acquired through conversion of previously awarded and vested restricted stock units (RSUs) under the Exelon Long Term Incentive Plan.
Footnote F2
Vesting of previously granted restricted stock unit (RSU) awarded under Exelon Long Term Incentive Plan. Awards granted annually to vest in 1/3 increments at the January or February meetings of the Compensation Committee with each RSU representing the right to receive one share of Exelon common stock upon vesting. RSUs accrue quarterly dividend equivalents in the form of additional RSUs representing common stock dividends as approved by the Board, which vest on the same schedule as the underlying RSU award.
Footnote F3
The RSU award accrued 880 additional shares during 2021 through automatic dividend reinvestment.
Footnote F4
The RSU award accrued 1,710 additional shares during 2021 through automatic dividend reinvestment.
Footnote F5
The RSU award accrued 2,692 additional shares during 2021 through automatic dividend reinvestment.
Footnote F6
Phantom share equivalents held in the Exelon stock fund within the Exelon Deferred Compensation Plan, which is multi-fund, non-qualified deferred compensation plan. The share equivalents within the fund will be settled in cash upon the reporting person's separation from the company for any reason. The balance includes 244 additional share equivalents acquired during 2021 through automatic dividend reinvestment.
Footnote F7
Balance reflects disposition of shares transferred pursuant to court-approved domestic relations order